BIOGEN IDEC

HM:IDP Germany Other
Market Cap
$1.66 Million
€1.62 Million EUR
Market Cap Rank
#34975 Global
#4084 in Germany
Share Price
€162.00
Change (1 day)
-1.61%
52-Week Range
€99.02 - €166.50
All Time High
€339.95
About

BIOGEN IDEC operates in Diversified Metals & Mining.

BIOGEN IDEC (IDP) - Net Assets

Latest net assets as of September 2024: €16.36 Billion EUR

Based on the latest financial reports, BIOGEN IDEC (IDP) has net assets worth €16.36 Billion EUR as of September 2024.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€28.31 Billion) and total liabilities (€11.95 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets €16.36 Billion
% of Total Assets 57.78%
Annual Growth Rate 2.88%
5-Year Change 10.95%
10-Year Change N/A
Growth Volatility 11.63

BIOGEN IDEC - Net Assets Trend (2016–2023)

This chart illustrates how BIOGEN IDEC's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for BIOGEN IDEC (2016–2023)

The table below shows the annual net assets of BIOGEN IDEC from 2016 to 2023.

Year Net Assets Change
2023-12-31 €14.80 Billion +10.54%
2022-12-31 €13.39 Billion +22.16%
2021-12-31 €10.96 Billion +2.56%
2020-12-31 €10.69 Billion -19.89%
2019-12-31 €13.34 Billion +2.36%
2018-12-31 €13.03 Billion +3.44%
2017-12-31 €12.60 Billion +3.87%
2016-12-31 €12.13 Billion --

Equity Component Analysis

This analysis shows how different components contribute to BIOGEN IDEC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 17.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2023)

Component Amount Percentage
Retained Earnings €17.63 Billion 119.11%
Total Equity €14.80 Billion 100.00%

BIOGEN IDEC Competitors by Market Cap

The table below lists competitors of BIOGEN IDEC ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in BIOGEN IDEC's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2022 to 2023, total equity changed from 13,397,900,000 to 14,799,400,000, a change of 1,401,500,000 (10.5%).
  • Net income of 1,161,100,000 contributed positively to equity growth.
  • Other factors increased equity by 240,400,000.

Equity Change Factors (2022 to 2023)

Factor Impact Contribution
Net Income €1.16 Billion +7.85%
Other Changes €240.40 Million +1.62%
Total Change €- 10.46%

Book Value vs Market Value Analysis

This analysis compares BIOGEN IDEC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.59x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 2.72x to 1.59x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 €59.63 €162.00 x
2018-12-31 €66.12 €162.00 x
2019-12-31 €76.60 €162.00 x
2020-12-31 €70.21 €162.00 x
2021-12-31 €74.12 €162.00 x
2022-12-31 €93.04 €162.00 x
2023-12-31 €102.14 €162.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently BIOGEN IDEC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 7.85%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 11.81%
  • • Asset Turnover: 0.37x
  • • Equity Multiplier: 1.81x
  • Recent ROE (7.85%) is below the historical average (26.37%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2016 30.50% 32.34% 0.50x 1.88x €2.49 Billion
2017 20.13% 20.69% 0.52x 1.88x €1.28 Billion
2018 33.98% 32.93% 0.53x 1.94x €3.13 Billion
2019 44.13% 40.96% 0.53x 2.04x €4.55 Billion
2020 37.39% 29.76% 0.55x 2.30x €2.93 Billion
2021 14.28% 14.17% 0.46x 2.19x €466.48 Million
2022 22.74% 29.95% 0.41x 1.83x €1.71 Billion
2023 7.85% 11.81% 0.37x 1.81x €-318.84 Million

Industry Comparison

This section compares BIOGEN IDEC's net assets metrics with peer companies in the Other industry.

Industry Context

  • Industry: Other
  • Average net assets among peers: $114,212,818,724
  • Average return on equity (ROE) among peers: -9.08%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
BIOGEN IDEC (IDP) €16.36 Billion 30.50% 0.73x $1.55 Million
HORIBA (01H) $204.49 Billion 10.42% 0.82x $989.01K
Tokyu Corporation (01T) $779.37 Billion 3.34% 2.35x $99.73K
GUANGZHOU AUTO -H- (02G) $122.28 Billion 6.59% 0.55x $4.05K
MOSAIC (02M) $10.60 Billion 4.43% 0.90x $280.83K
MOSAIC (02M.SG) (02M) $9.56 Billion 10.46% 0.82x $247.21K
CHINA JO-JO DRGSTRS (04CN.SG) (04CN) $16.67 Million -126.83% 4.46x $1.55 Million
KRAKATAU STEEL -B- (07K) $552.59 Million 3.52% 4.72x $166.99
CN MODERN DAIRY (07M) $7.12 Billion -10.42% 1.50x $1.68K
TOURMALINE OIL (08T) $7.22 Billion 4.81% 0.41x $381.02K
ASIA CASSAVA RESOUR (0ACS) $913.15 Million 2.86% 1.55x $325.03